A novel preribosomal complex in trypanosomes
锥虫中的一种新型前核糖体复合物
基本信息
- 批准号:8448653
- 负责人:
- 金额:$ 35.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2015-03-31
- 项目状态:已结题
- 来源:
- 关键词:African TrypanosomiasisAntibioticsBacteriaBindingBinding ProteinsBiogenesisBiological AssayCell NucleolusCell NucleusChagas DiseaseChemicalsComplexComputer SimulationDataDatabasesDiseaseDrug TargetingEnergy TransferFluorescenceGelGoalsHomologous GeneHumanImmuneIn VitroInterventionKetolidesLeishmaniaLeishmaniasisMacrolidesMaintenanceMapsMediatingMethodsMolecularMutationNucleoplasmOrganismParasitesPathway interactionsPlayProcessProtein Binding DomainProtein FragmentProteinsRNA-Binding ProteinsResearchResolutionRibosomal Biogenesis PathwayRibosomal RNARoleRouteSignal TransductionSmall RNAStagingStructureSystemTechnologyTestingTranscription Factor TFIIIATrypanosomaTrypanosoma brucei bruceiTrypanosoma cruziWorkbasechemotherapydomain mappingin vivomigrationnovelparticlepublic health relevanceresearch studyribosomal protein L5screeningtrafficking
项目摘要
DESCRIPTION (provided by applicant): We have shown that two trypanosome-specific RNA binding proteins, P34 and P37, play an essential role in the ribosomal biogenesis pathway in T. brucei. This represents a novel finding since the ribosomal pathway is highly conserved. To exploit this observation for the ultimate goal of targeting the T. brucei ribosomal pathway in chemotherapy, we must understand the mechanism by which these proteins act in the pathway. In recent work, we have shown that P34 and P37 interact with both L5 and 5S rRNA, the highly conserved components of the preribosomal particle. Loss of P34/P37 leads to a decrease in 5S rRNA levels and other effects in ribosomal formation. The objective of this proposal is to determine the critical residues involved in this interaction and develop a method to identify molecules that disrupt this interaction. Our hypothesis is that the molecular interactions of these proteins will provide a valid target for intervention in ribosomal assembly in T. brucei. The specific aims of the project are to: 1. Determine the critical molecular determinants on L5 and P34/P37 that are required for participation in the T. brucei preribosomal complex. 2. Determine the critical regions on 5S rRNA that interact with L5 and P34/P37 in the T. brucei preribosomal complex. 3. Determine whether the interaction of P34/P37 with L5 and 5S rRNA is required for trafficking of the complex to the nucleolus. 4. Develop a FRET (fluorescence energy transfer) based screen for the disruption of the interaction between P34/P37, L5, and 5S rRNA in the preribosomal particle. Differences in ribosomal structure and function between bacteria and the infected human host have provided targets for macrolide and ketolide antibiotics. Since this preribosomal particle is unique to kinetoplastids and play an essential role in the ribosomal structure and biogenesis in these organisms, mechanistic studies with this complex will allow us to define a strategic target for chemical intervention.
描述(由申请人提供):我们已经证明两种锥虫特异性RNA结合蛋白P34和P37在锥虫核糖体生物合成途径中起重要作用。布鲁塞。这是一个新的发现,因为核糖体途径是高度保守的。为了利用这一观察结果,最终目标是瞄准T。为了研究布鲁氏菌核糖体途径在化疗中的作用,我们必须了解这些蛋白在该途径中的作用机制。在最近的工作中,我们已经表明,P34和P37与L5和5S rRNA,前核糖体颗粒的高度保守的成分相互作用。P34/P37的缺失导致5S rRNA水平的降低和核糖体形成中的其他效应。该提案的目的是确定参与这种相互作用的关键残基,并开发一种方法来识别破坏这种相互作用的分子。我们的假设是,这些蛋白质的分子相互作用将提供一个有效的目标,在核糖体组装的干预在T。布鲁塞。该项目的具体目标是:1.确定参与T所需的L5和P34/P37上的关键分子决定因素。布氏杆菌前核糖体复合物。2.确定T细胞中与L5和P34/P37相互作用的5S rRNA关键区域。布氏杆菌前核糖体复合物。3.确定P34/P37与L5和5S rRNA的相互作用是否是将复合物运输到核仁所必需的。4.开发基于FRET(荧光能量转移)的筛选,以破坏前核糖体颗粒中P34/P37、L5和5S rRNA之间的相互作用。细菌和感染的人类宿主之间核糖体结构和功能的差异为大环内酯类和酮内酯类抗生素提供了靶点。由于这种前核糖体颗粒是动质体所特有的,并在这些生物体的核糖体结构和生物发生中发挥重要作用,因此对这种复合物的机制研究将使我们能够确定化学干预的战略目标。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Characterization of a novel association between two trypanosome-specific proteins and 5S rRNA.
- DOI:10.1371/journal.pone.0030029
- 发表时间:2012
- 期刊:
- 影响因子:3.7
- 作者:Ciganda M;Williams N
- 通讯作者:Williams N
Association of a novel preribosomal complex in Trypanosoma brucei determined by fluorescence resonance energy transfer.
通过荧光共振能量转移测定布氏锥虫中新型前核糖体复合物的关联。
- DOI:10.1128/ec.00316-12
- 发表时间:2013
- 期刊:
- 影响因子:0
- 作者:Wang,Lei;Ciganda,Martin;Williams,Noreen
- 通讯作者:Williams,Noreen
A novel association between two trypanosome-specific factors and the conserved L5-5S rRNA complex.
- DOI:10.1371/journal.pone.0041398
- 发表时间:2012
- 期刊:
- 影响因子:3.7
- 作者:Ciganda M;Prohaska K;Hellman K;Williams N
- 通讯作者:Williams N
Eukaryotic 5S rRNA biogenesis.
- DOI:10.1002/wrna.74
- 发表时间:2011-07
- 期刊:
- 影响因子:7.3
- 作者:Ciganda, Martin;Williams, Noreen
- 通讯作者:Williams, Noreen
Kinetoplastid Specific RNA-Protein Interactions in Trypanosoma cruzi Ribosome Biogenesis.
- DOI:10.1371/journal.pone.0131323
- 发表时间:2015
- 期刊:
- 影响因子:3.7
- 作者:Umaer K;Williams N
- 通讯作者:Williams N
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Noreen Williams其他文献
Noreen Williams的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Noreen Williams', 18)}}的其他基金
相似海外基金
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
- 批准号:
EP/Y023528/1 - 财政年份:2024
- 资助金额:
$ 35.74万 - 项目类别:
Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
- 批准号:
BB/Y007611/1 - 财政年份:2024
- 资助金额:
$ 35.74万 - 项目类别:
Research Grant
Hitting bacteria with a Bam: Lectin-Like Antimicrobials as New Antibiotics
用 Bam 击中细菌:凝集素类抗菌剂作为新型抗生素
- 批准号:
DP230102150 - 财政年份:2023
- 资助金额:
$ 35.74万 - 项目类别:
Discovery Projects
Systematic identification of synthetic interactions in bacteria towards the next-generation of antibiotics
系统鉴定细菌与下一代抗生素的合成相互作用
- 批准号:
468567 - 财政年份:2022
- 资助金额:
$ 35.74万 - 项目类别:
Operating Grants
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
- 批准号:
FL210100071 - 财政年份:2022
- 资助金额:
$ 35.74万 - 项目类别:
Australian Laureate Fellowships
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
- 批准号:
10708102 - 财政年份:2022
- 资助金额:
$ 35.74万 - 项目类别:
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
- 批准号:
10587015 - 财政年份:2022
- 资助金额:
$ 35.74万 - 项目类别:
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
- 批准号:
10581945 - 财政年份:2021
- 资助金额:
$ 35.74万 - 项目类别:
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
- 批准号:
10358855 - 财政年份:2021
- 资助金额:
$ 35.74万 - 项目类别:
Developing novel antibiotics from natural products against resistant bacteria
从天然产物中开发针对耐药细菌的新型抗生素
- 批准号:
2599490 - 财政年份:2021
- 资助金额:
$ 35.74万 - 项目类别:
Studentship














{{item.name}}会员




